Lee Jones is listed as an executive officer and director on 4 SEC Form D filings by 2 issuers between Nov 2011 and Sep 2017: Rebiotix Inc. (Roseville, MN — biotechnology — 2011–2017; $18M reported sold to 29 investors) and ALGOS THERAPEUTICS INC (Roseville, MN — other health care — 2013).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 6 years. Across those companies the filings report $18M sold in total.
Listed alongside Erwin Kelen (3 shared filings), Michael Berman (3 shared filings), William McGuire (2 shared filings), Ganesh Iyer (1 shared filing), Gary P. Smaby (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Lee. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Lee Jones and found 7 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "LEE C JONES" (FL) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.